Sculptra Aesthetic Buttock Injections Two (367.5mg) Vials Online. Sculptra Aesthetic is typically used to treat the signs of aging in the face, such as wrinkles, lines, and folds. It is particularly effective in treating deep folds around the nose and mouth, commonly known as nasolabial folds, and marionette lines. Sculptra Aesthetic can also be used to treat sunken cheeks, temples, and other areas of the face where volume loss has occurred.
Sculptra Aesthetic is an FDA-approved dermal filler that helps to stimulate collagen production in the skin. It is a unique botulinum injectable treatment that works by gradually restoring the natural volume of your skin over time, resulting in a more youthful appearance.
Sculptra Aesthetic is composed of poly-L-lactic acid (PLLA), which is a synthetic biodegradable material that has been used in various medical applications for many years. The PLLA in Sculptra Aesthetic is gradually broken down by the body, and as it is broken down, it stimulates collagen production in the skin. Collagen is a natural protein that gives skin its firmness, elasticity, and youthful appearance. As we age, the production of collagen slows down, resulting in wrinkles and sagging skin.
Sculptra Aesthetic Buttock Injections is typically used to treat the signs of aging in the face, such as wrinkles, lines, and folds. It is particularly effective in treating deep folds around the nose and mouth, commonly known as nasolabial folds, and marionette lines. Sculptra Aesthetic can also be used to treat sunken cheeks, temples, and other areas of the face where volume loss has occurred.
Sculptra Aesthetic similar to other botulinum toxin treatments, and it’s typically involves a series of injections over the course of several months. The number of injections required will depend on the severity of the areas being treated and the desired results. The injections are typically administered by a licensed healthcare provider, such as a dermatologist or plastic surgeon, and are generally well-tolerated by patients.
